Creative Medical Technology Holdings Inc. is a commercial stage biotechnology company focused on a regenerative approach to Immunotherapy, Urology, Neurology and Orthopedics. Creative Medical Technology Holdings Inc. is based in PHOENIX.
| Revenue (Most Recent Fiscal Year) | $0.01M |
| Net Income (Most Recent Fiscal Year) | $-5.49M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | -- |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 1.10 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -43492.86% |
| Net Margin (Trailing 12 Months) | -- |
| Return on Equity (Trailing 12 Months) | -85.26% |
| Return on Assets (Trailing 12 Months) | -81.49% |
| Current Ratio (Most Recent Fiscal Quarter) | 27.43 |
| Quick Ratio (Most Recent Fiscal Quarter) | 27.42 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.00 |
| Inventory Turnover (Trailing 12 Months) | 2.25 |
| Book Value per Share (Most Recent Fiscal Quarter) | $3.12 |
| Earnings per Share (Most Recent Fiscal Quarter) | $-0.83 |
| Earnings per Share (Most Recent Fiscal Year) | $-3.71 |
| Diluted Earnings per Share (Trailing 12 Months) | $-3.81 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Common Shares Outstanding | 2.59M |
| Free Float | 2.51M |
| Market Capitalization | $5.21M |
| Average Volume (Last 20 Days) | 0.03M |
| Beta (Past 60 Months) | 2.00 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 2.80% |
| Percentage Held By Institutions (Latest 13F Reports) | 1.42% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |